Could Your Gut Be the Key to Calmer Skin? Understanding the Gut–Skin Axis

Could Your Gut Be the Key to Calmer Skin? Understanding the Gut–Skin Axis

If you have ever noticed that a stressful week or a particularly indulgent weekend seems to show up on your face — whether as redness, breakouts, or a sudden flare of a skin condition — you are not imagining things. Scientists have spent years investigating what is now known as the gut–skin axis: the remarkable bidirectional relationship between what is happening in your digestive system and the health of your skin. And the evidence is growing that looking after your gut could be one of the most powerful things you do for your complexion.

What Is the Gut–Skin Axis?

The gut and the skin might seem worlds apart, but they share a surprising number of characteristics. Both are large barrier organs that interact constantly with the external environment. Both are densely populated by microorganisms, and both play a central role in regulating the immune system (1).

The gut microbiome — the vast community of bacteria, fungi, and other microbes living in your gastrointestinal tract — acts as a kind of command centre for immune activity throughout the body. When this community is balanced and diverse, it helps maintain a healthy intestinal lining and keeps inflammation in check. It achieves this partly through the production of short-chain fatty acids (SCFAs) such as butyrate, which strengthen the gut barrier and reduce the tendency of immune cells to overreact (1).

When the balance is disrupted — a state known as dysbiosis — the gut lining can become more permeable, sometimes referred to as a "leaky gut." This allows bacterial fragments and toxins to enter the bloodstream, triggering a systemic inflammatory response that can manifest in distant organs, including the skin (1). Researchers have described this chain of events as a core mechanism linking gut health to a wide range of chronic skin conditions, including acne vulgaris, atopic dermatitis, psoriasis, and rosacea (1).

Rosacea: More Than Skin Deep

Rosacea is a chronic inflammatory skin condition affecting around 5.5% of the general population. It typically presents as persistent facial redness, flushing, papules, pustules, and sometimes burning or stinging sensations, most often across the cheeks, nose, forehead, and chin (3). For many people, it fluctuates unpredictably, flaring in response to triggers such as heat, spicy food, alcohol, stress, or — as emerging evidence suggests — disturbances in the gut microbiome.

The association between rosacea and gastrointestinal conditions has been well documented. Studies have found significantly higher rates of conditions such as inflammatory bowel disease, irritable bowel syndrome, coeliac disease, small intestinal bacterial overgrowth (SIBO), and Helicobacter pylori infection among rosacea patients compared to the general population (2), (3). A large Danish cohort study involving nearly 50,000 rosacea patients found that the prevalence of all these gastrointestinal conditions was significantly higher in the rosacea group (3).

What is particularly striking is that treating some of these gut conditions appears to calm rosacea as well. Eradication of SIBO using rifaximin has been shown in multiple studies to result in significant or complete resolution of rosacea skin lesions, with remission persisting for months or even years after treatment (2), (3). This is not merely coincidental — it points to a shared inflammatory pathway in which gut dysbiosis perpetuates the immune dysfunction driving rosacea.

The Immune Connection

Rosacea involves a chronically overactivated immune system. The skin of rosacea patients shows elevated levels of the antimicrobial peptide LL-37 and increased activity of toll-like receptor 2 (TLR-2), which amplifies the inflammatory response to external triggers — including microorganisms (3). This heightened sensitivity means that bacterial signals arriving from a dysbiotic gut, whether via the bloodstream or through altered immune cell behaviour, can plausibly worsen the inflammatory state of rosacea-prone skin.

Research into the gut microbiota of rosacea patients has identified meaningful differences from healthy controls. Studies have found altered abundance of several bacterial genera, including decreases in Prevotella, Lactobacillus, and Megasphaera, alongside increases in Bacteroides and Fusobacterium (3). These shifts are consistent with the kind of microbiome imbalance that drives systemic inflammation.

The gut–skin axis also operates through the nervous and endocrine systems. The gut is the body's largest endocrine organ, producing neurotransmitters and hormones — including serotonin, dopamine, and cortisol — that influence skin behaviour and inflammatory responses (1). Stress, which is known to exacerbate rosacea, also alters gut microbiome composition, completing what can become a frustrating cycle for sufferers.

How the Gut Microbiome Affects Skin More Broadly

The relationship between gut health and skin is not limited to rosacea. Research published in Microorganisms found consistent associations between gut dysbiosis and a range of common skin conditions (1):

  • Acne vulgaris: Patients have been shown to have reduced gut microbial diversity, with lower levels of beneficial Firmicutes and higher levels of Bacteroides (1).
  • Atopic dermatitis: Gut dysbiosis — including reduced Bifidobacterium and Akkermansia — is linked to the Th2-driven inflammation characteristic of this condition (1).
  • Psoriasis: Alterations in gut microbiome diversity and composition have been identified in psoriasis patients, and dietary interventions affecting the gut have shown impact on disease severity (1).

In each of these conditions, the same core mechanism appears relevant:

gut dysbiosis → impaired intestinal barrier → systemic immune activation → skin inflammation

Supporting gut health therefore has potential benefits that extend well beyond digestion.

Elly's Experience: When Gut Health Transformed Her Skin

We recently heard from Elly, one of our JUVIA customers, whose experience beautifully illustrates this gut–skin connection:

"I've really enjoyed using JUVIA. I noticed improvements in my digestion and bloating quite quickly, and I also felt that my rosacea calmed down while taking it regularly. The benefits were noticeable fast, and it was incredibly reassuring to have something that helped with symptoms that can often feel unpredictable.

What stood out most was how liberating it felt to simply feel 'normal' after eating, without constantly wondering how my body would react. It was easy to add into my daily routine as it mixed well into a drink before a main meal. When I stopped taking it for a few days, I quickly realised just how much it had been helping. Overall, it's been a simple addition to my routine that has made a noticeable difference to my day-to-day wellbeing, and I'd happily recommend it to anyone struggling with digestive discomfort and bloating." — Elly, JUVIA customer

Elly's experience resonates with what the science is increasingly telling us: that improving digestive function and rebalancing the gut environment can have visible, felt effects on inflammatory skin conditions. The speed at which she noticed results, and the return of symptoms when she paused, reflects how directly and dynamically gut health can influence skin.

Where JUVIA Comes In

JUVIA is built around ERME™ (Enzyme Rich Malt Extract), a natural barley-derived ingredient containing over 15 active enzymes. These enzymes begin breaking down food before it reaches the lower gut — reducing the fermentation and microbial imbalances that contribute to bloating, digestive discomfort, and the systemic inflammation that can drive skin conditions.

Unlike probiotics, which introduce foreign bacteria into the gut, JUVIA works to support your body's own existing microbiome — helping to rebalance the environment rather than simply adding to it. Research into ERME™ has demonstrated that it can promote beneficial bacteria while reducing harmful ones, supporting the kind of microbial diversity that is associated with both good digestive health and reduced systemic inflammation.

By improving gut barrier integrity and reducing the burden of dysbiosis, JUVIA may help interrupt the chain of events that connects poor gut health to skin flares. For conditions like rosacea, where the gut–skin connection appears particularly significant, this kind of upstream support could make a meaningful difference to day-to-day symptoms.

JUVIA is taken as 10ml (two teaspoons) three times daily, just before meals — a simple routine that, as Elly found, is easy to maintain and can produce noticeable effects relatively quickly.

Looking After Your Gut to Look After Your Skin

The gut–skin axis is one of the more exciting areas of health research right now, and the evidence supporting it is accumulating rapidly. While more large-scale clinical trials are needed to fully map the mechanisms at play, the existing body of research is consistent and compelling: the health of your gut microbiome matters for your skin.

If you are someone who experiences unpredictable skin flares, persistent redness, or inflammatory skin conditions alongside digestive symptoms — whether that is bloating, urgency, discomfort, or IBS — it may be worth considering whether supporting your gut could offer relief from both.

As Elly discovered, sometimes the answer to what is happening on the outside begins with what is happening on the inside.


This blog is intended for informational purposes only and does not constitute medical advice. If you have a diagnosed skin or gastrointestinal condition, please consult your healthcare professional.

References

  1. (1) De Pessemier, B., Grine, L., Debaere, M., Maes, A., Paetzold, B., & Callewaert, C. (2021). Gut–skin axis: Current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms, 9(2), 353. https://doi.org/10.3390/microorganisms9020353
  2. (2) Wang, F.-Y., & Chi, C.-C. (2021). Rosacea, germs, and bowels: A review on gastrointestinal comorbidities and gut–skin axis of rosacea. Advances in Therapy, 38(3), 1415–1424. https://doi.org/10.1007/s12325-021-01624-x
  3. (3) Sánchez-Pellicer, P., Eguren-Michelena, C., García-Gavín, J., Llamas-Velasco, M., Navarro-Moratalla, L., Núñez-Delegido, E., Agüera-Santos, J., & Navarro-López, V. (2024). Rosacea, microbiome and probiotics: the gut-skin axis. Frontiers in Microbiology, 14, 1323644. https://doi.org/10.3389/fmicb.2023.1323644